Future studies with a large population cohort focused on genotyping additional polymorphisms to capture more of the variations in the VDR gene, and haplotype analysis to elucidate the role of the VDR gene as a prostate cancer risk factor may benefit the expansion of significant data. This evidence concerns the gene VDR and prostate cancer.